Fig. 5From: The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosisForest plot for the pooled response rate of AML with 95% confidence intervals in LAM patients treated with sirolimus or everolimus. Random effects model is suitable for single-arm analysis. The pooled response rate of AML for LAM patients treated with sirolimus or everolimus was 0.62 (95% CI: 0.43 to 0.82) and 0.78 (95% CI: 0.68 to 0.88), respectivelyBack to article page